Reviews
6 June 2014
Vol. 66 No. 1 (2014)
https://doi.org/10.4081/reumatismo.2014.769

Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Emotional disorders, Antidepressants, Psychotherapeutic strategies.
2752
Views
1780
Downloads

Authors

R. Torta
riccardo.torta@unito.it
Clinical and Oncological Psychology Unit, University of Turin, Italy.
F. Pennazio
Clinical and Oncological Psychology Unit, University of Turin, Italy.
V. Ieraci
Clinical and Oncological Psychology Unit, University of Turin, Italy.
The high prevalence of emotional disorders (anxiety, chronic stress, mood depression) in patients with pain during rheumatologic diseases (particularly fibromyalgia) is closely related to the common pathogenic mechanisms concerning emotions and pain. Therefore a prompt identification of any psychic component of pain, also by means of specific tools, is a must, because it can require an adjustment of the therapeutic approach by combining both an analgesic treatment and antidepressants and/or psychotherapeutic strategies.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite



Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management. (2014). Reumatismo, 66(1), 92-97. https://doi.org/10.4081/reumatismo.2014.769

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.